Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12096
Abstract: Abstract Pulmonary hypertension secondary to heart failure (HF‐PH) combined with pulmonary vascular remodeling has a high mortality rate. Apolipoprotein A1 (ApoA1) has been shown to adversely affect outcomes in patients with HF. A prospective follow‐up… read more here.
Keywords: apoa1; pulmonary hypertension; apoa1 levels; pulmonary vascular ... See more keywords
Association of urinary ketamine and APOA1 levels with bladder dysfunction in ketamine abusers revealed via proteomics and targeted metabolite analyses
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-89089-4
Abstract: Chronic ketamine abuse is associated with bladder dysfunction and cystitis. However, the effects of ketamine abuse on the urinary proteome profile and the correlations among urinary proteins, urinary ketamine (and metabolites) and clinicopathological features of… read more here.
Keywords: apoa1 levels; bladder dysfunction; ketamine; urinary ketamine ... See more keywords
U-shaped Relationship between Apolipoprotein A1 Levels and Mortality Risk in Men and Women.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwac263
Abstract: BACKGROUND Apolipoprotein A1 (ApoA1) is the principal protein component of high-density lipoprotein (HDL). Although low HDL cholesterol (HDL-C) levels are known to be associated with greater cardiovascular risk, recent studies have also shown heightened mortality… read more here.
Keywords: levels mortality; apoa1 levels; shaped relationship; mortality ... See more keywords
Monocyte Subset Recruitment Marker Profile Is Inversely Associated With Blood ApoA1 Levels
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.616305
Abstract: Dyslipidemia promotes development of the atherosclerotic plaques that characterise cardiovascular disease. Plaque progression requires the influx of monocytes into the vessel wall, but whether dyslipidemia is associated with an increased potential of monocytes to extravasate… read more here.
Keywords: recruitment marker; recruitment; monocyte subsets; apoa1 levels ... See more keywords